Immune Checkpoint Inhibitor-Related Pneumonitis in Lung Cancer: Real-World Incidence, Risk Factors, and Management Practices Across Six Health Care Centers in North Carolina

Immune checkpoint inhibitors (ICIs) are standard treatments for advanced non-small cell lung cancer and have expanded use in small cell lung cancer. Although generally better tolerated than traditional chemotherapy, immune-related adverse events, such as immune checkpoint inhibitor-related pneumonit...

Full description

Saved in:
Bibliographic Details
Published in:Chest 2021-08, Vol.160 (2), p.731-742
Main Authors: Atchley, William T, Alvarez, Carolina, Saxena-Beem, Shruti, Schwartz, Todd A, Ishizawar, Rumey C, Patel, Kunal P, Rivera, M Patricia
Format: Article
Language:English
Subjects:
Aged
Case-Control Studies
Female
Humans
Immune Checkpoint Inhibitors - adverse effects
Incidence
Lung Neoplasms - drug therapy
Male
Middle Aged
North Carolina - epidemiology
Pneumonia - chemically induced
Pneumonia - diagnostic imaging
Pneumonia - epidemiology
Pneumonia - mortality
Retrospective Studies
Risk Factors
Spirometry
Thoracic Oncology: Original Research
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!